Bachiller S, Jiménez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T, Boza-Serrano A (2018) Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Frontiers in Cellular Neuroscience 12
Brigas HC, Ribeiro M, Coelho JE, Gomes R, Gomez-Murcia V, Carvalho K, Faivre E, Costa-Pereira S, Darrigues J, de Almeida AA, Buée L, Dunot J, Marie H, Pousinha PA, Blum D, Silva-Santos B, Lopes LV, Ribot JC (2021) IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer’s disease. Cell Rep 36:109574
Article CAS PubMed Google Scholar
Calvo-Flores Guzmán B, Elizabeth Chaffey T, Hansika Palpagama T, Waters S, Boix J, Tate WP, Peppercorn K, Dragunow M, Waldvogel HJ, Faull RLM, Kwakowsky A (2020) The interplay between Beta-Amyloid 1–42 (Aβ1–42)-Induced hippocampal inflammatory response, p-tau, vascular pathology, and their synergistic contributions to neuronal death and behavioral deficits. Front Mol Neurosci 13:552073
Cao M, Liu J, Zhang X, Wang Y, Hou Y, Song Q, Cui Y, Zhao Y, Wang P (2023) IL-17A promotes the progression of Alzheimer’s disease in APP/PS1 mice. Immun Ageing 20:74
Article CAS PubMed PubMed Central Google Scholar
Chen JM, Jiang GX, Li QW, Zhou ZM, Cheng Q (2014) Increased serum levels of interleukin-18, -23 and– 17 in Chinese patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 38:321–329
Article CAS PubMed Google Scholar
Chen J, Liu X, Zhong Y (2020) Interleukin-17A: the key cytokine in neurodegenerative diseases. Front Aging Neurosci 12:566922
Article CAS PubMed PubMed Central Google Scholar
Chung SH, Ye XQ, Iwakura Y (2021) Interleukin-17 family members in health and disease. Int Immunol 33:723–729
Article CAS PubMed PubMed Central Google Scholar
Cristiano C, Volpicelli F, Lippiello P, Buono B, Raucci F, Piccolo M, Iqbal AJ, Irace C, Miniaci MC, Perrone Capano C, Calignano A, Mascolo N, Maione F (2019) Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment. 176:3544–3557
D’Anna L, Abu-Rumeileh S, Fabris M, Pistis C, Baldi A, Sanvilli N, Curcio F, Gigli GL, D’Anna S, Valente M (2017) Serum Interleukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in alzheimer disease patients. Neuro-degener Dis 17:227–234
de la Monte SM, Daiello LA, Hapel AJ, Tong M, Ott BRJJNN (2017) Altered serum and cerebrospinal fluid inflammatory cascades in mild cognitive impairment and Alzheimer’s disease. J Neuroinflammation Neurodegenerative Dis 1:100004
Di Benedetto G, Burgaletto C, Bellanca CM, Munafò A, Bernardini R, Cantarella G (2022) Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca(2+) Homeostasis Dysregulation. Cells 11.
Domingues C, da Cruz ESOAB, Henriques AG (2017) Impact of cytokines and chemokines on Alzheimer’s disease neuropathological hallmarks. Curr Alzheimer Res 14:870–882
Article CAS PubMed PubMed Central Google Scholar
Dubenko OE, Chyniak OS, Potapov OO (2021) Levels of Proinflammatory cytokines il-17 and il-23 in patients with Alzheimer’s disease, mild cognitive impairment and vascular dementia. Wiadomości Lekarskie 74:68–71
Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556–567
Article CAS PubMed PubMed Central Google Scholar
Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Therapy 8:359
Gautam AS, Pulivarthi Cb, Singh RK (2023) Proinflammatory IL-17 levels in serum/cerebrospinal fluid of patients with neurodegenerative diseases: a meta-analysis study. Naunyn Schmiedebergs Arch Pharmacol 396:577–588
Article CAS PubMed Google Scholar
Ghafarimoghadam M, Mashayekh R, Gholami M, Fereydani P, Shelley-Tremblay J, Kandezi N, Sabouri E, Motaghinejad M (2022) A review of behavioral methods for the evaluation of cognitive performance in animal models: current techniques and links to human cognition. Physiol Behav 244:113652
Article CAS PubMed Google Scholar
Góth L (1991) A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 196:143–151
Green HF, Khosousi S, Svenningsson P (2019) Plasma IL-6 and IL-17A correlate with severity of motor and Non-Motor symptoms in Parkinson’s disease. J Parkinson’s Disease 9:705–709
Hadwan MH, Abed HN (2016) Data supporting the spectrophotometric method for the Estimation of catalase activity. Data Brief 6:194–199
Hamdan AA, Melconian AK, Adhia AH, Alhaidary AF (2014) The level of IL-1α, IL-10 and IL-17A in Alzheimer’s disease patients: comparative study. Baghdad Sci J 11:1486–1492
Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The Amyloid-β pathway in Alzheimer’s disease. Mol Psychiatry 26:5481–5503
Article CAS PubMed PubMed Central Google Scholar
Imbimbo BP, Ippati S, Watling M, Imbimbo C (2023) Role of monomeric amyloid-β in cognitive performance in Alzheimer’s disease: insights from clinical trials with secretase inhibitors and monoclonal antibodies. Pharmacol Res 187:106631
Article CAS PubMed Google Scholar
Kim CF, Moalem-Taylor G (2011) Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J Pain 12:370–383
Article CAS PubMed Google Scholar
Kiraly M, Foss JF, Giordano T (2023) Neuroinflammation, its role in Alzheimer’s disease and therapeutic strategies. J Prev Alzheimer’s Disease 10:686–698
Lasure VU, Singh Gautam A, Singh RK (2024) Quercetin ameliorates neuroinflammatory and neurodegenerative biomarkers in the brain and improves neurobehavioral parameters in a repeated intranasal amyloid-beta exposed model of Alzheimer’s disease. Food & Function
Li X, Bechara R, Zhao J, McGeachy MJ, Gaffen SL (2019) IL-17 receptor–based signaling and implications for disease. Nat Immunol 20:1594–1602
Article CAS PubMed PubMed Central Google Scholar
Lim YY, Maruff P, Kaneko N, Doecke J, Fowler C, Villemagne VL, Kato T, Rowe CC, Arahata Y, Iwamoto S, Ito K, Tanaka K, Yanagisawa K, Masters CL, Nakamura A (2020) Plasma Amyloid-β biomarker associated with cognitive decline in preclinical Alzheimer’s disease. J Alzheimers Dis 77:1057–1065
Article CAS PubMed Google Scholar
Liu D, Du D (2020) Mulberry fruit extract alleviates cognitive impairment by promoting the clearance of Amyloid-β and inhibiting neuroinflammation in Alzheimer’s disease mice. Neurochem Res 45:2009–2019
Article CAS PubMed Google Scholar
Liu Y, Meng Y, Zhou C, Yan J, Guo C, Dong W (2023) Activation of the IL-17/TRAF6/NF-κB pathway is implicated in Aβ-induced neurotoxicity. BMC Neurosci 24:14
Article CAS PubMed PubMed Central Google Scholar
Lu Y, Zhang P, Xu F, Zheng Y, Zhao H (2023) Advances in the study of IL-17 in neurological diseases and mental disorders. 14
Luo H, Liu H-Z, Zhang W-W, Matsuda M, Lv N, Chen G, Xu Z-Z, Zhang Y-Q (2019) Interleukin-17 regulates Neuron-Glial communications, synaptic transmission, and neuropathic pain after chemotherapy. Cell Rep 29:2384–2397e2385
Article CAS PubMed Google Scholar
Mandal PK (2024) Pro-Oxidants and antioxidants imbalance in Alzheimer’s disease. J Alzheimers Dis 99:S1–s4
Article CAS PubMed Google Scholar
Martín-Belmonte A, Aguado C, Alfaro-Ruíz R, Itakura M, Moreno-Martínez AE, de la Ossa L, Molnár E, Fukazawa Y, Luján R (2020) Age-Dependent shift of AMPA receptors from synapses to intracellular compartments in Alzheimer’s disease: immunocytochemical analysis of the CA1 hippocampal region in APP/PS1 Transgenic mouse model. Front Aging Neurosci 12:577996
Article PubMed PubMed Central Google Scholar
Mayo L, Jacob-Hirsch J, Amariglio N, Rechavi G, Moutin MJ, Lund FE, Stein R (2008) Dual role of CD38 in microglial activation and activation-induced cell death. J Immunol 181:92–103
Article CAS PubMed Google Scholar
Mills KHG (2023) IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol 23:38–54
Comments (0)